Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2024 Earnings Call Transcript March 6, 2025
Arcturus Therapeutics Holdings Inc. misses on earnings expectations. Reported EPS is $-1.11 EPS, expectations were $-0.33.
Operator: Good day, everyone, and welcome to Arcturus Therapeutics Fourth and Full Year 2024 Earnings Call. [Operator Instructions] Please note, today’s call will be recorded [Operator Instructions] It is now my pleasure to turn the conference over to Neda Safarzadeh, Vice...
